ATE510905T1 - Verfahren zur isolierung von bipotenten lebervorläuferzellen - Google Patents
Verfahren zur isolierung von bipotenten lebervorläuferzellenInfo
- Publication number
- ATE510905T1 ATE510905T1 AT00968708T AT00968708T ATE510905T1 AT E510905 T1 ATE510905 T1 AT E510905T1 AT 00968708 T AT00968708 T AT 00968708T AT 00968708 T AT00968708 T AT 00968708T AT E510905 T1 ATE510905 T1 AT E510905T1
- Authority
- AT
- Austria
- Prior art keywords
- progenitors
- cells
- hepatic
- antigen
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2000/027429 WO2002028997A2 (en) | 2000-10-03 | 2000-10-03 | Methods of isolating bipotent hepatic progenitor cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE510905T1 true ATE510905T1 (de) | 2011-06-15 |
Family
ID=21741847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00968708T ATE510905T1 (de) | 2000-10-03 | 2000-10-03 | Verfahren zur isolierung von bipotenten lebervorläuferzellen |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1325112B1 (de) |
JP (1) | JP2004510432A (de) |
CN (1) | CN1258589C (de) |
AT (1) | ATE510905T1 (de) |
AU (2) | AU2000278582B2 (de) |
CA (1) | CA2424781C (de) |
DK (1) | DK1325112T3 (de) |
ES (1) | ES2367005T3 (de) |
HK (1) | HK1054569B (de) |
IL (2) | IL155249A0 (de) |
WO (1) | WO2002028997A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020187133A1 (en) | 1999-10-01 | 2002-12-12 | Hiroshi Kubota | Methods of isolating bipotent hepatic progenitor cells |
WO2002029012A1 (en) * | 2000-10-03 | 2002-04-11 | University Of North Carolina | Processes for clonal growth of hepatic progenitor cells |
EP1381673B1 (de) | 2001-03-27 | 2009-05-13 | Vertex Pharmaceuticals Incorporated | Für hcv-infektion geeignete zusammensetzungen und verfahren |
CN1665920A (zh) | 2001-06-22 | 2005-09-07 | 干细胞股份有限公司 | 肝移植细胞、测定及其应用 |
CA2553303C (en) * | 2004-01-14 | 2014-06-10 | Novahep Ab | Human hepatic progenitor cells and methods of use thereof |
EP2179034A1 (de) * | 2007-07-20 | 2010-04-28 | Cellartis AB | Neue population von über definitives endoderm (de-hep) von menschlichen blastozysten-stammzellen abgeleiteten hepatozyten |
WO2013026833A1 (en) * | 2011-08-23 | 2013-02-28 | Roche Glycart Ag | Bispecific t cell activating antigen binding molecules |
KR20190003833A (ko) | 2014-08-28 | 2019-01-09 | 프로메테라 바이오사이언시즈 에스.에이./엔.브이. | 성체 간 전구 세포의 제조 방법 |
CA2968065C (en) | 2014-11-26 | 2024-04-09 | Jau-Nan Lee | Induced hepatocytes and uses thereof |
JP6704617B2 (ja) * | 2016-01-29 | 2020-06-03 | 北海道公立大学法人 札幌医科大学 | 小型肝細胞の継代培養方法 |
CN109385394A (zh) * | 2018-11-02 | 2019-02-26 | 大连理工大学 | 一种提取、分离和培养同体异种肝原代细胞的方法 |
US20220049225A1 (en) * | 2018-12-14 | 2022-02-17 | Promethera Therapeutics Sa | Cell composition comprising liver progenitor cells expressing hla-e |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6129911A (en) * | 1998-07-10 | 2000-10-10 | Rhode Island Hospital, A Lifespan Partner | Liver stem cell |
JP5068901B2 (ja) * | 1999-01-19 | 2012-11-07 | ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | ヒト肝前駆細胞 |
-
2000
- 2000-10-03 AT AT00968708T patent/ATE510905T1/de active
- 2000-10-03 JP JP2002532568A patent/JP2004510432A/ja active Pending
- 2000-10-03 IL IL15524900A patent/IL155249A0/xx unknown
- 2000-10-03 CA CA2424781A patent/CA2424781C/en not_active Expired - Fee Related
- 2000-10-03 ES ES00968708T patent/ES2367005T3/es not_active Expired - Lifetime
- 2000-10-03 EP EP00968708A patent/EP1325112B1/de not_active Expired - Lifetime
- 2000-10-03 CN CNB008200483A patent/CN1258589C/zh not_active Expired - Fee Related
- 2000-10-03 AU AU2000278582A patent/AU2000278582B2/en not_active Ceased
- 2000-10-03 AU AU7858200A patent/AU7858200A/xx active Pending
- 2000-10-03 DK DK00968708.8T patent/DK1325112T3/da active
- 2000-10-03 WO PCT/US2000/027429 patent/WO2002028997A2/en active Application Filing
-
2003
- 2003-04-03 IL IL155249A patent/IL155249A/en not_active IP Right Cessation
- 2003-09-19 HK HK03106717.6A patent/HK1054569B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1461340A (zh) | 2003-12-10 |
WO2002028997A2 (en) | 2002-04-11 |
WO2002028997A3 (en) | 2002-09-12 |
CA2424781C (en) | 2018-11-06 |
DK1325112T3 (da) | 2011-09-12 |
ES2367005T3 (es) | 2011-10-27 |
EP1325112A2 (de) | 2003-07-09 |
AU7858200A (en) | 2002-04-15 |
JP2004510432A (ja) | 2004-04-08 |
CA2424781A1 (en) | 2002-04-11 |
IL155249A0 (en) | 2003-11-23 |
HK1054569A1 (en) | 2003-12-05 |
AU2000278582B2 (en) | 2007-08-30 |
EP1325112B1 (de) | 2011-05-25 |
HK1054569B (zh) | 2012-03-02 |
IL155249A (en) | 2011-12-29 |
CN1258589C (zh) | 2006-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wong et al. | Multilineage potential and self-renewal define an epithelial progenitor cell population in the adult thymus | |
Joseph et al. | Urethral luminal epithelia are castration‐insensitive cells of the proximal prostate | |
ATE510905T1 (de) | Verfahren zur isolierung von bipotenten lebervorläuferzellen | |
CN103989710B (zh) | 分离的肝脏干细胞 | |
Austin et al. | Hepatic regeneration from hematopoietic stem cells | |
DK1115840T3 (da) | Afstamningsspecifikke celler og progenitorceller | |
WO2003104411A3 (en) | BIOARTIFICIAL LIVER SYSTEM | |
CN101553564B (zh) | 肝星状细胞前体及其分离方法 | |
Soh et al. | CD166pos subpopulation from differentiated human ES and iPS cells support repair of acute lung injury | |
JP2012507304A5 (de) | ||
O'Connor et al. | Differentiation rather than aging of muscle stem cells abolishes their telomerase activity | |
BRPI0710339A2 (pt) | método de modulação de uma reação imunólogica, método de redução e extrato | |
Bao et al. | Establishment and characterization of immortalized gingival epithelial and fibroblastic cell lines for the development of organotypic cultures | |
Cunningham et al. | Regulation and function of adhesion molecule expression by human alveolar epithelial cells. | |
Tang et al. | Hlf expression marks early emergence of hematopoietic stem cell precursors with adult repopulating potential and fate | |
ATE310816T1 (de) | Verfahren zur bestimmung einer genfunktion | |
Almeida-Porada et al. | A large animal noninjury model for study of human stem cell plasticity | |
Reynolds et al. | Lung epithelial healing: a modified seed and soil concept | |
Borena et al. | Sphere-forming capacity as an enrichment strategy for epithelial-like stem cells from equine skin | |
CN106834217A (zh) | 一种促进人羊膜上皮细胞体外扩增的方法及应用 | |
Pitt et al. | Stem cells in lung biology | |
Pouliot et al. | Optimization of a transplant model to assess skin reconstitution from stem cell‐enriched primary human keratinocyte populations | |
Zheng et al. | Embryonic lineage tracing with Procr-CreER marks balanced hematopoietic stem cell fate during entire mouse lifespan | |
Lambert et al. | The influence of three-dimensional structure on naïve T cell homeostasis and aging | |
SG11201806182RA (en) | Methods of producing viruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1325112 Country of ref document: EP |